An Open-Label Pilot Study of Metformin as a Concomitant Therapy on Patients with Prostate Cancer Undergoing Androgen Deprivation Treatment

Publisher： Karger

E-ISSN： 1423-0399|98|1|79-84

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.98, Iss.1, 2016-09, pp. : 79-84

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Titration of Dosage for the Protective Effect of Zoledronic Acid on Bone Loss in Patients Submitted to Androgen Deprivation Therapy due to Prostate Cancer: A Prospective Open-Label Study

By  

Urologia Internationalis, Vol. 85, Iss. 2, 2010-07 ,pp. : 180-185

Karger

Access to resources Recommend Favorite

Exercise programme to reduce treatment toxicity when initiating ADT

By  

BJU INTERNATIONAL, Vol. 115, Iss. 2, 2015-02 ,pp. : 256-266

John Wiley & Sons Inc

Access to resources Recommend Favorite

Androgen Deprivation Therapy in Prostate Cancer - Current Status in M1 Patients

By  

Oncology Research and Treatment, Vol. 38, Iss. 12, 2015-0 ,pp. : 646-652

Karger

Access to resources Recommend Favorite

Metabolic changes in patients with prostate cancer during androgen deprivation therapy

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 25, Iss. 1, 2018-01 ,pp. : 45-53

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prospective Study of Estramustine Phosphate for Hormone Refractory Prostate Cancer Patients following Androgen Deprivation Therapy

By  

Urologia Internationalis, Vol. 75, Iss. 1, 2005-07 ,pp. : 43-49

Karger

Access to resources Recommend Favorite